160 HEALTH (02656) saw its shares rise nearly 3% during the trading session. As of the time of writing, the stock was up 2.58%, trading at HKD 20.7 with a turnover of HKD 350 million.

On the news front, following the official release of the new flagship large language model DeepSeek-V4, 160 HEALTH has swiftly adapted by completing the deployment and integration of the DeepSeek-V4 series models. This move positions the company among the first in the digital healthcare sector to implement this advanced model. The technological upgrade signifies a new phase in the company's "Platform + AI + Operations" strategy.

Reportedly, 160 HEALTH is integrating DeepSeek-V4 into its core AI products, such as its intelligent triage and pre-consultation systems. This integration enables a comprehensive analysis of patients' multi-year, cross-institutional data, leading to more accurate triage recommendations and directly enhancing conversion rates and user engagement.

According to the company's latest disclosed announcement, as of March 31, 2026, its "160AI Hospital" operational partnership model has achieved a significant breakthrough. The cumulative number of public medical institutions that have entered into operational partnerships has reached 102. Notably, over half of these are top-tier (Grade III A) hospitals. The combined annual outpatient volume of these partner hospitals is approximately 84.37 million visits.